Biomolecules & Therapeutics

  • 제17권3호
  • /
  • Pages.325-331
  • /
  • 2009
  • /
  • 1976-9148(pISSN)
  • /
  • 2005-4483(eISSN)
한국응용약물학회 (The Korean Society of Applied Pharmacology)
권호 표지
DOI QR코드

DOI QR Code

Single Oral Dose Toxicity Test of Low Molecular Weight Fucoidan in Rats

  • Yoon, Hyun-Soo (Department of Anatomy and Cell Biology, Hanyang University College of Medicine) ;
  • Shin, Yong-Kyu (BION Co., Ltd.) ;
  • Jung, Young-Mi (Department of Genetic Engineering, College of Natural Sciences, Kyungpook National University) ;
  • Lee, Hyeung-Sik (Department of Clinical Laboratory Science, College of Health and Therapy, Daegu Haany University) ;
  • Ku, Sae-Kwang (Department of Anatomy and Histology, College of Oriental Medicine, Daegu Haany University)
  • 발행 : 2009.07.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The object of this study was to evaluate the single oral dose toxicity of Low Molecular Weight Fucoidan (LMF) in male and female rats. LMF was administered to female and male SD rats as an oral dose of 2,000, 1,000 and 500 mg/kg (body wt.). Animals were monitored for the mortality and changes in body weight, clinical signs and gross observation organ weight and histopathology of 14 principle organs were examined upon necropsy. As the results, no LMF treatment related mortalities, clinical signs, changes on the body and organ weights, gross and histopathological observations against 14 principle organs were detected up to 2,000 mg/kg in both female and male rats except for some sporadic findings not LMF treatment related toxicological signs. Therefore, $LD_{50}$ (50% lethal dose) and approximate LD of LMF after single oral treatment in female and male rats were considered over 2,000 mg/kg - the limited dosages recommended by KFDA Guidelines [2005-60, 2005], respectively.

키워드

참고문헌

  1. Alkhatib, B., Freguin-Bouilland, C., Lallemand, F., Henry, J. P., Litzler, P. Y., Marie, J. P., Richard, V., Thuillez, C. and Plissonnier, D. (2006). Low molecular weight fucan prevents transplant coronaropathy in rat cardiac allograft model. Transpl. Immunol. 16, 14-19 https://doi.org/10.1016/j.trim.2006.03.003
  2. Banks, W. J. (1986). Female reproductive system. In Applied veterinary histology (W. J. Banks, Ed.), pp. 506-526. Williams & Wilkins, Baltimore
  3. Be'ress, A., Wassermann, O., Tahhan, S., Bruhn, T., Beress, L. and Kraiselburd, E. N. (1993). A new procedure for the isolation of anti-HIV compounds (polysaccharide and polyphenols) from the marine algae Fucus vesiculosus. J. Nat. Prod. 56, 478-488 https://doi.org/10.1021/np50094a005
  4. Berteau, O. and Mulloy, B. (2003). Sulfated fucans, fresh perspectives: structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide. Glycobiology 13, 29R-40R https://doi.org/10.1093/glycob/cwg058
  5. Blondin, C., Chaubet, F., Nardella, A., Sinquin, C. and Jozefonvicz, J. (1996). Relationships between chemical characteristics and anticomplementary activity of fucans. Biomaterials 17, 597-603 https://doi.org/10.1016/0142-9612(96)88710-2
  6. Bojakowski, K., Abramczyk, P., Bojakowska, M., Zwolinska, A., Przybylski, J. and Gaciong, Z. (2001). Fucoidan improves the renal blood flow in the early stage of renal ischemia/reperfusion injury in the rat. J. Physiol. Pharmacol. 52, 137-143
  7. Boorman, G. A., Eustis, S. L., Elwell, M. R., Montgomery, C. A. Jr. and Mackenzie, W. F. (1990). Pathology of the Fischer Rat. Reference and Atlas. Academic Press, San Diego
  8. Colliec, S., Fischer, A. M., Tapon-Bretaudiere, J., Boisson, C., Durand, P. and Jozefonvicz, J. (1991). Anticoagulant properties of a fucoidan fraction. Thromb. Res. 64, 143-154 https://doi.org/10.1016/S0049-3848(97)00037-6
  9. Dourish, C. T. (1987). Effects of drugs on spontaneous motor activity. In Experimental Psychopharmacology (A. J. Greenshaw and C. T. Dourish, Ed.), pp. 325-334. Humana Press, Clifton
  10. Dubois, M., Gilles, K. A., Hamilton, J. K., Rebers, P. A. and Smith, F. (1956). Colorimetric method for determination of sugars and related substances. Anal. Chem. 28, 350-354 https://doi.org/10.1021/ac60111a017
  11. Farndale, R. W., Buttle, D. J. and Barret, A. J. (1986). Improved quantification and discrimination of sulphated glycosaminoglycans by use of dimethylene blue. Biochim. Biophys. Acta. 883, 173-177 https://doi.org/10.1016/0304-4165(86)90306-5
  12. Fox, J. G., Cohen, B. J. and Loew, F. M. (1984). Laboratory animal medicine. Academic Press, Orlando
  13. Freguin-Bouilland, C., Alkhatib, B., David, N., Lallemand, F., Henry, J. P., Godin, M., Thuillez, C. and Plissonnier, D. (2007). Low molecular weight fucoidan prevents neointimal hyperplasia after aortic allografting. Transplantation 83, 1234-1241 https://doi.org/10.1097/01.tp.0000261109.97928.9c
  14. Greaves, P. (1990). Histopathology of Preclinical Studies: Interpretation and Relevance in Drug Evaluation. Elsevier, New York
  15. Haroun-Bouhedja, F., Ellouali, M., Sinquin, C. and Boisson-Vidal, C. (2000). Relationship between sulfate groups and biological activities of fucans. Thromb. Res. 100, 453-459 https://doi.org/10.1016/S0049-3848(00)00338-8
  16. Hasechek, W. M. and Rousseaux, C. G. (1998). Fundamanentals of Toxicologic Pathology. Academic Press, San Diego
  17. Irwin, S. (1968). Comprehensive observational assessment: Ia. A systemic, quantitative procedure for assessing the behavioral and physiological state of the mouse. Psychopharmacology 13, 222-257 https://doi.org/10.1007/BF00401402
  18. Jung, Y. M., Kim, T. K., Park, D. C. and Lee, Y. H. (2007). Bioavailable Fucoidan and Methods for Preparing the Same, Korean Patent 0705975
  19. Jung, Y. M., Yoo, K. M., Park, D. C., Kim, T. K., Lee, H. S. and Ku S. K. (2008). Oral single dose toxicity study of low molecular fucoidan in mice. Toxicol. Res. 24, 79-86 https://doi.org/10.5487/TR.2008.24.1.079
  20. Korea Food and Drug Administration. (2005). Testing Guidelines for Safety Evaluation of Drugs (Notification No. 2005-60, issued by the Korea Food and Drug Administration on October 21, 2005)
  21. Lake, A. C., Vassy, R., Di Benedetto, M., Lavigne, D., Le Visage, C., Perret, G. Y. and Letourneur, D. (2006). Low molecular weight fucoidan increases VEGF165-induced endothelial cell migration by enhancing VEGF165 binding to VEGFR-2 and NRP1. J. Biol. Chem. 281, 37844-37852 https://doi.org/10.1074/jbc.M600686200
  22. Li, N., Zhang, Q. and Song, J. (2005). Toxicological evaluation of fucoidan extracted from Laminaria japonica in Wistar rats. Food Chem. Toxicol. 43, 421-426 https://doi.org/10.1016/j.fct.2004.12.001
  23. Marais, M. F. and Joseleau, J. P. (2001). A fucoidan fraction from Ascophyllum nodosum. Carbohydr. Res. 336, 155-159 https://doi.org/10.1016/S0008-6215(01)00257-9
  24. Matsubara, K., Xue, C., Zhao, X., Mori, M., Sugawara, T. and Hirata, T. (2005). Effects of middle molecular weight fucoidans on in vitro and ex vivo angiogenesis of endothelial cells. Int. J. Mol. Med. 15, 695-699
  25. Nardella, A., Chaubet, F., Sinquin, C., Colliec Jouault, S., Boisson-Vidal, C., Durand, P. and Jozefonvicz, J. (2000). Method for Obtaining Sulfated Polysaccharides. United States Patent 6,028,191
  26. Patankar, M. S., Oehninger, S., Barnett, T., Williams, R. L. and Clark, G. F. (1993). A revised structure for fucoidan may explain some of its biological activities. J. Biol. Chem. 268, 21770-21776.
  27. Pineda, M. H. (1989). Female reproductive system. In Veterinary Endocrinology and Reproduction (L. E. McDonald and M. H. Pineda, Eds.). pp. 303-354. Lea & Febiger, Philadelphia.
  28. Senni, K., Gueniche, F., Foucault-Bertaud, A., Igondjo-Tchen, S., Fioretti, F., Colliec-Jouault, S., Durand, P., Guezennec, J., Godeau, G. and Letourneur, D. (2006). Fucoidan a sulfated polysaccharide from brown algae is a potent modulator of connective tissue proteolysis. Arch. Biochem. Biophys. 445, 56-64 https://doi.org/10.1016/j.abb.2005.11.001
  29. Shimizu, J., Wada-Funada, U., Mano, H., Matahira, Y., Kawaguchi, M. and Wada, M. (2005). Proportion of murine cytotoxic T cells is increased by high molecular-weight fucoidan extracted from Okinawa mozuku (Cladosiphon okamuranus). J. Health Sci. 51, 394-397 https://doi.org/10.1248/jhs.51.394
  30. Tajima, Y. (1989). Biological reference data book on experimental animals. Soft Science Inc, Tokyo.
  31. Zemani, F., Benisvy, D., Galy-Fauroux, I., Lokajczyk, A., Colliec-Jouault, S., Uzan, G., Fischer, A. M. and Boisson-Vidal, C. (2005). Low-molecular-weight fucoidan enhances the proangiogenic phenotype of endothelial progenitor cells. Biochem. Pharmacol. 70, 1167-1175 https://doi.org/10.1016/j.bcp.2005.07.014

피인용 문헌

  1. Genotoxicity testing of low molecular weight fucoidan from brown seaweeds vol.50, pp.3-4, 2012, https://doi.org/10.1016/j.fct.2011.11.010
  2. Single Oral Dose Toxicity Study of Prebrewed Armeniacae Semen in Rats vol.29, pp.2, 2013, https://doi.org/10.5487/TR.2013.29.2.091
  3. Low molecular weight fucoidan ameliorates streptozotocin-induced hyper-responsiveness of aortic smooth muscles in type 1 diabetes rats vol.191, 2016, https://doi.org/10.1016/j.jep.2016.06.054
  4. 14 Days Repeat Oral Dose Toxicity of Low Molecular Weight Fucoidan in Rats vol.18, pp.1, 2010, https://doi.org/10.4062/biomolther.2010.18.1.111